Reporter July 8 2022
Probing the tumor microenvironment
Jul. 12, 2022—Vanderbilt researchers used single-cell sequencing, imaging, and computational approaches to characterize the colonic tumor microenvironment, providing important insights to the components that play roles in colorectal tumor pathogenesis.
A speedier treatment for depression?
Jul. 11, 2022—Vanderbilt researchers used a computer-based search to identify a compound with promise as a new, mechanistically distinct and rapid-acting therapy for major depressive disorder.
Preempting sudden cardiac death
Jul. 7, 2022—A technique to characterize all variants in genes associated with arrhythmia could improve the ability to identify and preemptively treat individuals at risk for sudden cardiac death.
Professionalism and patient outcomes
Jul. 7, 2022—A study of more than 70,000 trauma patients found that those who received care from a service with a high proportion of physicians modeling unprofessional behavior were at a 24% increased risk of death or complications.
New Junior League gift celebrates 100 years of support
Jul. 7, 2022—by Christina Echegaray For 100 years, the Junior League of Nashville has been a champion of children’s health care, impacting the lives of countless patients and families through its commitment to service and philanthropy. The group has a rich legacy that features a long-standing partnership with Monroe Carell Jr. Children’s Hospital at Vanderbilt, carrying out...
Breaking the stigma of AIDS part of Raffanti’s long legacy
Jul. 7, 2022—On June 29 Stephen Raffanti, MD, MPH, hung up his scrubs at the Vanderbilt Comprehensive Care Clinic for the last time. It was a bittersweet moment for the man who helped lead Nashville out of the darkest days of the AIDS epidemic 30 years ago.
Convalescent plasma doesn’t help severely ill COVID patients: study
Jul. 7, 2022—A Vanderbilt clinical trial shows that convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover
Study seeks to disprove cephalosporin allergies
Jul. 7, 2022—A Vanderbilt study shows that taking a careful history in patients who report allergies to cephalosporins and separating them into risk categories can help identify which patients are at low risk to be truly allergic to these antibiotics.
Vanderbilt Psychiatric Hospital adds social work fellowship program
Jul. 7, 2022—Vanderbilt Psychiatric Hospital has launched a new social work fellowship which will prepare master’s degree-level graduates for social work in the behavioral health field.
Mathers Foundation award supports study of crosstalk between skeletal, immune systems
Jul. 7, 2022—Vanderbilt's Jim Cassat, MD, PhD, has received a three-year, $750,000 award from the G. Harold and Leila Y. Mathers Foundation to support research exploring the interplay between bone homeostasis and infectious disease.
Jul. 7, 2022—Nashville was the host city for the recent Health Occupations Students of America leadership conference and the Vanderbilt Eye Institute was invited to host a competition.
Ward honored by National Psoriasis Foundation
Jul. 7, 2022—Vanderbilt's Nicole Ward, PhD, was one of three honorees who were the focus of attention at the National Psoriasis Foundation’s 2022 Commit to Cure Gala: Celebrating Women Who Lead, held recently in Chicago.